Inventor · disambiguated record
Wolf-Hagen Schunck
Also filed as: SCHUNCK WOLF-HAGEN
5 granted patents·2 pending applications·5 citations·filing 2010–2022
68Inventor score
Files withMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3OMEICOS THERAPEUTICS GMBH3SCHUNCK WOLF-HAGEN1
Top patents by PatentIndex Score
7 records- 0171US9272991B2Eicosanoid derivativesSCHUNCK WOLF-HAGEN·Filed 2010·Granted Mar 1, 2016·4 cites·20 claims
- 0269US11365183B2Eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2019·Granted Jun 21, 2022·0 cites·13 claims
- 0368US10287262B2Eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2016·Granted May 14, 2019·1 cites·13 claims
- 0450US12370158B2Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammationOMEICOS THERAPEUTICS GMBH·Filed 2021·Granted Jul 29, 2025·0 cites·5 claims
- 0549US2025319054A1Synthetic Eicosanoid Analogues for the Treatment and Prevention of Diseases Associated with Increased GDF15 Plasma ConcentrationOMEICOS THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 0631US11130772B2CYP-eicosanoid derivativesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2015·Granted Sep 28, 2021·0 cites·14 claims
- 0731US2019117597A1Analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammationOMEICOS THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →